Stock BLUEJET BLUE JET HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Blue Jet Healthcare Limited

Equities

BLUEJET

INE0KBH01020

Pharmaceuticals

End-of-day quote NSE India S.E.
Other stock markets
 03:30:00 07/06/2024 am IST 		5-day change 1st Jan Change
385.4 INR +3.37% Intraday chart for Blue Jet Healthcare Limited +0.80% +4.69%
25/05 Blue Jet Healthcare Limited Recommends Final Dividend for the Financial Year Ended 31 March 2024 CI
25/05 Blue Jet Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2024 2025 2026
Capitalization 1 66,845 - -
Enterprise Value (EV) 1 63,234 64,264 63,749
P/E ratio 40.6 x 29.3 x 23.4 x
Yield 0.26% 0.75% 1.4%
Capitalization / Revenue 9.33 x 6.66 x 5.37 x
EV / Revenue 8.89 x 6.41 x 5.12 x
EV / EBITDA 27.6 x 20.3 x 16 x
EV / FCF 92.5 x -173 x 91.5 x
FCF Yield 1.08% -0.58% 1.09%
Price to Book 7.86 x 6.47 x 5.33 x
Nbr of stocks (in thousands) 1,73,465 - -
Reference price 2 385.4 385.4 385.4
Announcement Date 25/05/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2023 2024 2025 2026
Net sales 1 - 7,116 10,029 12,453
EBITDA 1 - 2,292 3,158 3,980
EBIT 1 - 2,011 2,732 3,417
Operating Margin - 28.27% 27.24% 27.44%
Earnings before Tax (EBT) 1 - 2,201 3,050 3,839
Net income 1 1,600 1,638 2,282 2,905
Net margin - 23.01% 22.76% 23.32%
EPS 2 9.230 9.440 13.15 16.48
Free Cash Flow 1 - 684 -372 697
FCF margin - 9.61% -3.71% 5.6%
FCF Conversion (EBITDA) - 29.84% - 17.51%
FCF Conversion (Net income) - 41.77% - 24%
Dividend per Share 2 - 1.000 2.900 5.400
Announcement Date 10/07/23 25/05/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2024 Q4
Net sales 1 1,971
EBITDA 1 613
EBIT 1 520
Operating Margin 26.38%
Earnings before Tax (EBT) 1 564
Net income 1 387
Net margin 19.63%
EPS 2 2.200
Dividend per Share -
Announcement Date -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2023 2024 2025 2026
Net Debt 1 - - - -
Net Cash position 1 - 3,186 2,581 3,096
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 - 684 -372 697
ROE (net income / shareholders' equity) - 22.4% 28.1% 27%
ROA (Net income/ Total Assets) - 17.8% 19.8% 19.3%
Assets 1 - 9,197 11,542 15,041
Book Value Per Share 2 - 48.70 59.60 72.30
Cash Flow per Share - - - -
Capex 1 - 1,729 1,788 1,667
Capex / Sales - 24.29% 17.83% 13.38%
Announcement Date 10/07/23 25/05/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
385.4 INR
Average target price
406.7 INR
Spread / Average Target
+5.53%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BLUE JET HEALTHCARE LIMITED Stock Blue Jet Healthcare Limited
+4.69% 80Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+45.82% 77TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.95% 63TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.16% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.86% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+9.32% 30TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 25TCr
ROCHE HOLDING AG Stock Roche Holding AG
-0.78% 22TCr
NOVARTIS AG Stock Novartis AG
+11.88% 22TCr
AMGEN INC. Stock Amgen Inc.
+5.90% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BLUEJET Stock
  4. Financials Blue Jet Healthcare Limited